DNA FOUND IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES MAY NOT BE REQUIRED FOR INFECTIVITY

被引:32
|
作者
ARTS, EJ
MAK, J
KLEIMAN, L
WAINBERG, MA
机构
[1] MCGILL UNIV,JEWISH GEN HOSP,LADY DAVIS INST MED RES,MONTREAL H3T 1E2,PQ,CANADA
[2] MCGILL UNIV,DEPT MICROBIOL & IMMUNOL,MONTREAL H3A 2B4,PQ,CANADA
关键词
D O I
10.1099/0022-1317-75-7-1605
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have studied the presence and significance of retroviral genome-derived DNA in the core of human immunodeficiency virus (HIV) particles produced from transfections of HXB2 expression vectors in COS-7 cells and from HIV type 1 IIIB chronically infected H9 cells. Viruses purified by sucrose cushion centrifugation and treated with DNase I contained 1000-fold more viral RNA than DNA. However protease-defective viruses that contained only p160(gag-pol) had less than 100 times the amount of DNA in their cores than wild-type viruses suggesting that the p66/p51 form of reverse transcriptase was responsible for DNA transcription. Viruses produced by transfections in the presence of 3'-azido-3'-deoxythymidine (AZT) contained the viral RNA genome but only DNA of premature length because of the chain terminating effects of AZT. However such viruses were as infectious for CD4(+) cells as wild-type virus. We conclude that retrovirus-derived DNA in HIV-1 particles is not required for infection and does not play a significant role in this process.
引用
收藏
页码:1605 / 1613
页数:9
相关论文
共 50 条
  • [41] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY OZONE INVITRO
    WELLS, KH
    LATINO, J
    GAVALCHIN, J
    POIESZ, BJ
    BLOOD, 1991, 78 (07) : 1882 - 1890
  • [42] ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    COLL, J
    YAZBECK, H
    GUTIERREZ, J
    MEDICINA CLINICA, 1993, 100 (09): : 357 - 358
  • [43] NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS
    AIKEN, C
    TRONO, D
    JOURNAL OF VIROLOGY, 1995, 69 (08) : 5048 - 5056
  • [44] MUTATION IN THE PRIMER BINDING-SITE OF THE TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS GENOME AFFECTS VIRUS PRODUCTION AND INFECTIVITY
    NAGASHUNMUGAM, T
    VELPANDI, A
    GOLDSMITH, CS
    ZAKI, SR
    KALYANARAMAN, VS
    SRINIVASAN, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) : 4114 - 4118
  • [45] THE TAT GENE AND PROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CAPUTO, A
    GROSSI, MP
    ROSSI, C
    CAMPIONI, D
    BALBONI, PG
    CORALLINI, A
    BARBANTIBRODANO, G
    MICROBIOLOGICA, 1995, 18 (01): : 87 - 110
  • [46] RAPID ENZYMATIC ANALYSIS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA IN CLINICAL SPECIMENS
    SEVALL, JS
    PRINCE, H
    GARRATTY, G
    OBRIEN, WA
    ZACK, JA
    CLINICAL CHEMISTRY, 1993, 39 (03) : 433 - 439
  • [47] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE BY CURCUMIN
    MAZUMDER, A
    RAGHAVAN, K
    WEINSTEIN, J
    KOHN, KW
    POMMIER, Y
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (08) : 1165 - 1170
  • [48] CURRENT STATUS OF THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LANE, HC
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 486 - 489
  • [49] HYDROXYCHLOROQUINE TREATMENT OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SPERBER, K
    LOUIE, M
    KRAUS, T
    PRONER, J
    SAPIRA, E
    LIN, S
    STECHER, V
    MAYER, L
    CLINICAL THERAPEUTICS, 1995, 17 (04) : 622 - 636
  • [50] MOLECULAR INSIGHTS INTO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PATHOGENESIS
    FEINBERG, MB
    GREENE, WC
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 466 - 474